Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Mammoth Biosciences

Biotech & Life Sciences · Brisbane, United States · Founded 2017 Unicorn

The CRISPR-based platform for disease detection

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value

Investors

19 investors on Mammoth Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 2 investors entered at this stage
Series A 4 investors entered at this stage
Kairos
8VC
Mayfield
Tectonic Capital
Series B+ 13 investors entered at this stage
University of California
Berkeley
Regeneron Pharmaceuticals
Pacific 8 Ventures
Brook Byers
Sixth Street Growth
Redmile Group
aMoon Fund
Greenspring Associates
Foresite Capital
Decheng Capital
Plum Alley
Senator Investment Group

Ownership

Who owns Mammoth Biosciences

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

27% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Mammoth Biosciences has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States98.2%
🇸🇬 Singapore0.8%
🇦🇺 Australia0.8%
🇬🇧 United Kingdom0.8%
4 countries shown
Web traffic by country
14K monthly visits
across markets
🇺🇸 United States78.6%
🇮🇳 India20.7%
🇨🇦 Canada4.3%
🇵🇱 Poland0%
Top 4 markets shown

Talent graph

The shape of Mammoth Biosciences's talent

Dealroom maps Mammoth Biosciences's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

7 standout operatorsDealroom-flagged across the org
4 AI specialistsincl. 1 core researchers
165 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Mammoth Biosciences's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$22M patent portfolio · 47 active families

Estimated portfolio value
$22M
2.2% of valuation · 191.8× larger than top peer Benchling ($113k)
47 active patent families
Where Mammoth Biosciences innovates Molecular biologyNucleic acidCRISPREffectorNuclease

Where Mammoth Biosciences concentrates vs peers

Each axis is a top-10 topic across Mammoth Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Mammoth Biosciences

An AI-synthesized read of the highest-engagement posts about Mammoth Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mammoth Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.